Dibromodulcitol in the treatment of metastatic hemangiopericytoma.
Publication/Presentation Date
8-1-1982
Abstract
Hemangiopericytoma is an uncommon sarcoma arising from the pericapillary cells. While the rarity of this lesion precludes randomized investigation, metastatic hemangiopericytoma has been noted to respond to a variety of agents, including vincristine, adriamycin, actinomycin, and high-dose methotrexate. We wish to report an unusual case of this disease which failed to respond to the above but then exhibited a marked response to dibromodulcitol. In light of the unusual nature of this response, we would like to suggest a controlled trial of the use of dibromodulcitol in patients with this rare tumor.
Volume
5
Issue
4
First Page
453
Last Page
456
ISSN
0277-3732
Published In/Presented At
Conroy, J. F., Roda, P. I., & Prasasvinichai, S. (1982). Dibromodulcitol in the treatment of metastatic hemangiopericytoma. American journal of clinical oncology, 5(4), 453–456. https://doi.org/10.1097/00000421-198208000-00019
Disciplines
Medicine and Health Sciences
PubMedID
7113966
Department(s)
Department of Medicine
Document Type
Article